 |
 |

Endocrine Aspects of Exophthalmos
EDWARD ROSE, M.D.
AMA Arch Ophthalmol. 1956;56(5):668-670.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
This discussion will be limited to the unique constellation of ophthalmopathic phenomena in which exophthalmos is only one of several manifestations and which has been known variously as malignant or progressive exophthalmos, hyperophthalmopathic Graves' disease, exophthalmic ophthalmoplegia, and the infiltrative ophthalmopathy of Graves' disease. It is usually accompanied by hyperthyroidism but may occur in euthyroid persons or occasionally in patients who are in a hypothyroid state throughout. Milder variants of the syndrome have even been described in Cushing's disease. After more than a century of fruitless speculation concerning its etiology and pathogenesis, interest began to center on the adenohypophysis as an important factor about 20 years ago, and in 1944 the nosological concept of Mulvany1 further influenced this trend of thought. This concept divided exophthalmos into thyrotoxic and thyrotropic types. The former (thyrotoxic) included the milder syndromes manifested chiefly by exophthalmos, lid retraction, and thinning of the extrinsic muscles;
. . . [Full Text PDF of this Article]
Author Affiliations
Philadelphia
Professor of Clinical Medicine, School of Medicine, University of Pennsylvania; Chief, Endocrine Section, Medical Clinic, Hospital of the University of Pennsylvania.
Footnotes
Received for publication June 4, 1956.
Read in the Symposium on Management of Exophthalmos before the Sectional Meeting of the American College of Surgeons, Philadelphia, Feb. 16, 1956.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|